AlphaFold predicted structure
RNPC3 · Q96LT9

Mean pLDDT
67.4/ 100
Low
517 residues
Confidence breakdown
- Very high(≥ 90)34%
- Confident(70–90)14%
- Low(50–70)16%
- Very low(< 50)36%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RNA binding region (RNP1, RRM) containing 3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIUGR and IGF abnormalities
BIALLELIC, autosomal or pseudoautosomalPituitary hormone deficiency
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalBilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalMonogenic short stature
BIALLELIC, autosomal or pseudoautosomalisolated growth hormone deficiency, type 5
neurodegenerative disease
Decreased response to growth hormone stimulation test
dentures
isolated growth hormone deficiency type IA
chronic atrophic gastritis
multinodular goiter
placenta praevia
hereditary disease
systemic lupus erythematosus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
RNA-binding region-containing protein 3
Participates in pre-mRNA U12-dependent splicing, performed by the minor spliceosome which removes U12-type introns. U12-type introns comprises less than 1% of all non-coding sequences. Binds to the 3'-stem-loop of m(7)G-capped U12 snRNA
RNPC3 · Q96LT9

Mean pLDDT
67.4/ 100
Low
517 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0